CGAS and neoplasm: In colitis-associated cancer models, cGAS KO mice demonstrate increased intestinal inflammation, increased tumorigenesis, and tumors with higher grades of dysplasia. Colonic tumors in cGAS-deficient mice demonstrate higher ki67 and BrdU expression compared to WT mice as well as increased activation of STAT3, suggesting possible effects on tumor proliferation.